Titan Pharmaceutical: An Enticing Investment Opportunity

... followed by the U.S. patent office's approval of the Probuphine patent and a grant from the National Institutes of Health (NIH) to study Probuphine as a treatment for opiate dependence. Over the next two years, Titan completed a pivotal Phase III ...

http://seekingalpha.com/article/1298621-titan-pharmaceutical-an-enticing-investment-opportunity?source=feed